Nivolumab and cabozantinib versus standard of care in renal cell carcinoma | Prof Thomas Powles at ECC 2015 - 101271

Spotlight
Video

Nivolumab and cabozantinib versus standard of care in renal cell carcinoma | Prof Thomas Powles at ECC 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: Thomas Powles, MBBS, MRCP, MD, of Barts and The London School of Medicine and Dentistry, London, UK, discusses the results of clinical trials reported at the European Cancer Congress (ECC) 2015 in patients with previously treated renal cell carcinoma: CheckMate 025, a phase 3 clinical trial of nivolumab versus everolimus; and METEOR, a phase 3 clinical trial of cabozantinib versus everolimus.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 11/23/15
Added : 2 years ago
Category : Kidney Cancer



Recommended

Nothing found.

More From EMJ

Nothing found.